ADALIMUMAB
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices
ADALIMUMAB (12334E)
12334E
Manner of administration:Injection
Restriction (Streamlined authority code: 16991)
Indication: Moderate to severe ulcerative colitis
Treatment phase: Subsequent continuing treatment
